Actinogen Medical Limited (ASX: ACW) - Share Price

Current share price for ACW : $0.055 0.002 (3.77%)⁺

Actinogen Medical (ACW) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is an association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long-term cognitive health.

ACW General Information ⁺

ASX Code	ACW
Website	N/A
Industry/Sector	Biotechnology
Market Cap ($M)	213
ACW Share Price	$0.055
Day High	$0.055
Day Low	$0.053
Last Close	$0.053
ACW Share Price Movement	$0.00 ( 3.77% )

Prices as at 16:40, 9 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Actinogen Medical Limited (ACW) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Actinogen Medical Limited (ACW) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Actinogen Medical Limited (ACW) price-sensitive announcements

ACW - June 2026 Quarterly activity report & Appendix 4C

Actinogen Medical Limited announced its June 2026 quarterly activity report and Appendix 4

Actinogen Medical Limited (ACW)
30 Jul 2026 | 10:03 AM

ACW - Xanamem depression trial published in British J Psychiatry

Actinogen Medical Limited announced promising results from its Xanamem phase 2 depression

Actinogen Medical Limited (ACW)
20 Jul 2026 | 9:33 AM

ACW - ACW third positive XanaMIA trial data committee review

Actinogen Medical Limited announced the receipt of a third positive recommendation from th

Actinogen Medical Limited (ACW)
18 Jun 2026 | 8:57 AM

ACW - Actinogen receives positive scientific advice from EMA

Actinogen Medical Limited announced that it has received positive scientific advice from t

Actinogen Medical Limited (ACW)
28 May 2026 | 9:51 AM

Actinogen Medical Limited (ACW) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Actinogen Medical Limited (ACW) ORDINARY FULLY PAID	Health Care	$213	AGM date and closing date for director nominations	9 Oct 2026 9:10AM	$0.053	$0.055	risen by 3.77%
Actinogen Medical Limited (ACW) ORDINARY FULLY PAID	Health Care	$213	Application for quotation of securities - ACW	30 Sep 2026 1:04PM	$0.059	$0.055	fallen by 6.78%
Actinogen Medical Limited (ACW) ORDINARY FULLY PAID	Health Care	$213	Options underwriting cleansing notice	23 Sep 2026 12:35PM	$0.062	$0.055	fallen by 11.29%
Actinogen Medical Limited (ACW) ORDINARY FULLY PAID	Health Care	$213	Application for quotation of securities - ACW	23 Sep 2026 12:35PM	$0.062	$0.055	fallen by 11.29%
Actinogen Medical Limited (ACW) ORDINARY FULLY PAID	Health Care	$213	Underwriting of unlisted options completed	23 Sep 2026 12:34PM	$0.062	$0.055	fallen by 11.29%
Actinogen Medical Limited (ACW) ORDINARY FULLY PAID	Health Care	$213	ACW Alzheimers pivotal trial completes last patient visit	23 Sep 2026 8:47AM	$0.058	$0.055	fallen by 5.17%

ACW Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2026A	-$15.38	-$0.50	-6.10%	0.00%	0.0%
2025A	-$14.73	-$0.50	-18.30%	0.00%	0.0%
2024A	-$13.04	-$0.60	5.30%	0.00%	0.0%

ACW Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Actinogen Medical Limited (ACW)	$205M	-0.0612	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
CSL Limited (CSL)	$87,080M	0.7309	-0.4457	0.0602	11.2418	20.2810	19.1298	2.34%	2.32%	2.40%
Mesoblast Limited (MSB)	$2,513M	-0.4380	0.0000	0.0000	0.0000	0.0000	302.3438	0.00%	0.00%	0.00%
PYC Therapeutics Limited (PYC)	$2,488M	-0.3971	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Telix Pharmaceuticals Limited (TLX)	$5,394M	-1.3893	0.0000	-0.5226	0.0000	188.6905	395.2618	0.00%	0.00%	0.00%

ACW Directors

Name	Position	Start Date
Dr Steven Gourlay	Chief Executive Officer, Managing Director	24 Mar 2021
Dr Geoffrey Edward Duncan Brooke	Non-Executive Chairman, Non-Executive Director	1 Mar 2017
Dr George Morstyn	Non-Executive Director	1 Dec 2017
Mr Malcolm John McComas	Non-Executive Director	4 Apr 2019
Dr Nicki Vasquez	Non-Executive Director	1 Mar 2023

Actinogen Medical Limited (ACW) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
9 Sep 2026	BROOKE, Geoffrey	Exercise	Options	237,029	$0.038	$8,888.590
9 Sep 2026	BROOKE, Geoffrey	Buy	Indirect Shares	237,029	$0.038	$8,888.590
28 Aug 2026	BROOKE, Geoffrey	Issued	Direct Shares	275,331	$0.037	$10,324.910

See all changes in directors' interest & trades for Actinogen Medical Limited (ACW) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

ACW Management

Name	Position
Andrew Udell	Chief Commercial Officer
William Souter	Chief Financial Officer
Dana Hilt	Chief Medical Officer
Peter Webse	Company Secretary
Fujun Li	Head of Manufacturing
Michael Roberts	Investor Relations
Cheryl Townsend	Vice President of Clinical Operations

ACW Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Actinogen Medical Limited (ACW). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
203,275,557 (5.47%)	Dr Steven Gourlay

ACW Calendar of Events

Date	Event
26 August 2027	Report (Annual)
26 August 2027	Report (Prelim)
25 February 2027	Report (Interim)
30 November 2026	AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us